Health Condition 1: S434- Sprain of shoulder joint
Conditions
Interventions
Intervention1: Intravenous Dexmedetomidine
: Intra operative Intravenous Dexmedetomidine is given at the dosage of 1 mcg/kg over 20 minutes in patients of shoulder arthroscopic surgery with low dose
Sponsors
BLK MAX SUPER SPECIALITY HOSPITAL
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age group 18-50 years 2. ASA Grade I and II
Exclusion criteria
Exclusion criteria: 1. BMI >38 kg/m2 2. Pregnancy 3. Failure to provide written informed consent 4. Significant Psychiatric or Cognitive conditions interfering with consent or assessment 5. Pre-existing neurological deficits or neuropathy affecting the brachial plexus 6. Pre-existing chronic pain or opioid use 7. Significant renal or hepatic impairment 8. Severe bronchopulmonary disease including COPD and OSA 9. Contraindications to peripheral nerve block, including local skin infection, bleeding diathesis, coagulopathy, prior surgery in neck 10. Allergies to local anaesthetics, dexmedetomidine, or any component of multimodal analgesia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To study and compare the time required for the first rescue analgesia in the two groups. 2. To compare the total opioid consumption in the first 24 hours postoperatively between the two groups. Timepoint: 24 hours post operatively | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To compare the patient satisfaction score between the two groups at the conclusion of first 24 hours. 2. To study and compare the adverse effects, if any, in the two groups.Timepoint: 24 hours post operatively | — |
Countries
India
Contacts
Public ContactSUDDAPALLI SHAIK MOHAMMAD MALIK
BLK MAX SUPER SPECIALITY HOSPITAL
Outcome results
None listed